Drug intelligence / Profile preview

Cervarix + Boostrix Polio

Development stage
Unknown
Lead developer
GSK
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

**Cervarix + Boostrix Polio** refers to the concomitant administration of two vaccines: **Cervarix**, a recombinant vaccine targeting human papillomavirus (HPV) types 16 and 18 for the prevention of cervical cancer and precancerous lesions, and **Boostrix Polio**, a combined vaccine containing diphtheria toxoid, tetanus toxoid, acellular pertussis antigens, and inactivated poliovirus, indicated for booster immunization against diphtheria, tetanus, pertussis, and polio. Both vaccines stimulate the immune system to produce antibodies specific to their antigens, thus protecting against the targeted infections. Concomitant administration has been shown to not interfere with the immunogenicity of each component when given together.

Other names
Boostrix-IPVCombined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine
02

Targets

HPV16 (Human papillomavirus type 16)TT (Tetanus toxoid)HPV18 L1

Beyond the preview

Go deeper on Cervarix + Boostrix Polio.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cervarix + Boostrix Polio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call